Cryopreserved biopsy tissues of rectal cancer liver metastasis for assessment of anticancer drug response in vitro and in vivo.
Animals
Antineoplastic Agents
/ therapeutic use
Biomarkers, Tumor
/ genetics
Biopsy
Cryopreservation
Female
Humans
Liver Neoplasms
/ drug therapy
Male
Mice
Middle Aged
Rectal Neoplasms
/ drug therapy
Tissue Culture Techniques
/ methods
Treatment Outcome
Vitrification
Xenograft Model Antitumor Assays
biopsy
vitrification-based cryopreservation
precision-cut slice
RLM
OXA
Journal
Oncology reports
ISSN: 1791-2431
Titre abrégé: Oncol Rep
Pays: Greece
ID NLM: 9422756
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
17
01
2018
accepted:
14
06
2019
pubmed:
3
1
2020
medline:
22
8
2020
entrez:
3
1
2020
Statut:
ppublish
Résumé
Living tumors are of great scientific value for clinical medicine and basic research, especially for drug testing. An increasing number of drug tests fail due to the use of imperfect models. The aim of the present study was to develop a novel method combining vitrification‑based cryopreservation of tumor biopsies and precision‑cut slice cultivation for the assessment of anticancer drug responses. Biological characteristics of rectal cancer liver metastasis biopsies could be retained by vitrification‑based cryopreservation. The patient‑derived xenograft models were successfully established using both fresh and warmed biopsy tissues. Precision‑cut slicing provided a similar three‑dimensional architecture and heterogeneity to the original tumor. The positive drug responses in the xenograft model were consistent with those in precision‑cut slice cultures in vitro. The present study demonstrated that live tumor biopsies could be preserved using vitrification‑based cryopreservation. The warmed tissues developed xenograft tumors, which were also useful for either in vivo or in vitro anticancer drug testing. Precision‑cut slices derived from the warmed tissues provided an efficient tool to assess anticancer drug response in vitro.
Identifiants
pubmed: 31894341
doi: 10.3892/or.2019.7450
pmc: PMC6967191
doi:
Substances chimiques
Antineoplastic Agents
0
Biomarkers, Tumor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
405-414Références
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Biotechnol Lett. 2006 Sep;28(18):1415-23
pubmed: 16955350
Biotechnol J. 2014 Sep;9(9):1115-28
pubmed: 25174503
Transplant Proc. 2005 Dec;37(10):4625-9
pubmed: 16387185
Cryobiology. 2017 Oct;78:41-46
pubmed: 28716599
Radiother Oncol. 2016 Feb;118(2):369-74
pubmed: 26705682
Respir Res. 2005 Apr 27;6:40
pubmed: 15857506
Ther Adv Med Oncol. 2017 Aug;9(8):551-564
pubmed: 28794806
Breast Cancer Res. 2003;5(2):89-95
pubmed: 12631387
Dev Cell. 2010 Jun 15;18(6):884-901
pubmed: 20627072
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Biotechnol J. 2008 Oct;3(9-10):1172-84
pubmed: 18566957
Cell. 2016 Sep 22;167(1):260-274.e22
pubmed: 27641504
World J Gastroenterol. 2016 Aug 28;22(32):7215-25
pubmed: 27621569
J Vis Exp. 2015 Nov 07;(105):e53304
pubmed: 26575352
Medicine (Baltimore). 2016 Sep;95(39):e4095
pubmed: 27684791
Sci Rep. 2015 Dec 09;5:17187
pubmed: 26647838
Exp Cell Res. 2010 May 1;316(8):1324-31
pubmed: 20211171
Curr Oncol. 2017 Feb;24(1):e24-e34
pubmed: 28270729
Stem Cells Int. 2016;2016:7053872
pubmed: 28119740
J Clin Pathol. 2013 Mar;66(3):253-5
pubmed: 23076396
BMC Cancer. 2006 Apr 07;6:86
pubmed: 16603054
Lab Invest. 2013 May;93(5):528-42
pubmed: 23459371
Reprod Domest Anim. 2017 Apr;52 Suppl 2:235-241
pubmed: 27862433
Eur J Cancer. 2004 Apr;40(6):802-20
pubmed: 15120036
BMC Cancer. 2016 Feb 09;16:78
pubmed: 26860465